Jump to content
  • Use code SUMMERSALE

    to get 20% discount across our website. Exclusions apply.

    More Information
  • Navigate a rapidly changing environment

    With our GCP Inspection course, next running 8th October.

    View Programme
  • 3rd European QA Conference 2019

    Europe's largest quality event in the industry, book your early bird place now.

    View Programme

Who are RQA

The Research Quality Association (RQA) is a professional membership body dedicated to informing and advancing its members. We provide status and visibility for individuals engaged in the quality of research concerning pharmaceuticals, agrochemicals, chemicals and medical devices. Since our inception in 1977, the Association has increased and evolved to reflect regulatory changes, the growing impact of regulatory inspection and the ever-changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research.  

Read more+

Our Mission

1. To develop and promote quality standards in scientific research.

2. To facilitate knowledge sharing and transfer through:

  • Discussion
  • Training
  • Seminars
  • Forums 
  • Conferences
  • Publications
  • Podcasts
  • Partnership and co-operation

3. To liaise with regulatory agencies in the development and interpretation of regulations and guidance.

Newsletter

Sign up to the latest news and events.

Latest News

View all news

EU and US reach a milestone....

With the recognition by the US Food and Drug Administration (FDA) of Slovakia, the European Union and the United States have now fully implemented the mutual recognition agreement (MRA) for inspections of manufacturing sites for certain human medicines in their respective territories.....

Read more+

Updated Version of the Clinical Trials Regulation Questions & Answers Paper

Updated Version of the Clinical Trials Regulation Questions & Answers Paper

Read more+

GPvP - FDA issues final guidance for Industry on Risk Evaluation and Mitigation Strategies: Modifications and Revisions

Today, the U.S. Food and Drug Administration (FDA) issued a final guidance for industry entitled Risk Evaluation and Mitigation Strategies: Modifications and Revisions.

Read more+